Naturopathic Approach

Abstract

References

Yarnell E . Naturopathic Urology and Men’s Health. Wenatchee, Wash: Healing Mountain; 2001.

Morrison AS , Buring JE , Verhoek WG , et al. An international study of smoking and bladder cancer. J Urol. 1984;131:650-654.

Karagas MR , Tosteson TD , Morris JS , et al. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control. 2004;15:465-472.

Morris RD , Audet AM , Angelillo IF , Chalmers TC , Mosteller F . Chlorination, chlorination by-products, and cancer: a metaanalysis [published correction appears in Am J Public Health. 1993;83:1257]. Am J Public Health. 1992;82:955-963.

McGeehin MA , Reif JS , Becher JC , Mangione EJ . Case-control study of bladder cancer and water disinfection methods in Colorado. Am J Epidemiol. 1993;138:492-501.

Michaud DS , Spiegelman D , Clinton SK , et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med. 1999;340:1390-1397.

Bushman JL . Green tea and cancer in humans: a review of the literature. Nutr Cancer. 1998;31:151-159.

Castelao JE , Yuan JM , Gago-Dominguez M , et al. Carotenoids/ vitamin C and smoking-related bladder cancer. Int J Cancer. 2004;110:417-423.

Byar D , Blackard C . Comparison of placebo, pyridoxine and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology. 1977;10:556-561.

10.

Lamm DL , Riggs DR , Shriver JS , van Gilder PF , Rach JF , DeHaven JI . Megadose vitamins in bladder cancer: a doubleblind clinical trial. J Urol. 1994;151:21-26.

11.

Lamm DL , Riggs DR , Carpenter C , DeHave JI . Long term results of high-dose vitamin administration in patients with superficial bladder cancer [abstract]. J Am Coll Nutr. 1995;14:535-535. Abstract 45.

12.

Newling DWW , Robinson MRG , Smith PH , et al. Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer: results of a prospective, randomised phase III study performed by the EORTC GU Group. Eur Urol. 1995;27:110-116.

13.

Jacobs EJ , Henion AK , Briggs PJ , et al. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol. 2002;156:1002-1010.

14.

Aso Y , Akaza H , Kotake T , et al. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur Urol. 1995;27:104-109.

15.

Matsuzaki T . Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int J Food Microbiol. 1998;41:133-140.

16.

Gill HS , Rutherfurd KJ , Cross ML . Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol. 2001;21:264-271.

17.

Lim BK , Mahendran R , Lee YK , Bay BH . Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn J Cancer Res. 2002;93:36-41.

18.

Meydani SN , Ha WK . Immunological effects of yogurt. Am J Clin Nutr. 2000;71:861-872.

19.

Yang DA . Inhibitory effect of Chinese herb medicine zhuling on urinary bladder cancer: an experimental and clinical study [in Chinese]. Zhonghua Wai Ke Za Zhi. 1991;29:393-395, 399-399.

20.

Kurashige S , Akuzawa Y , Endo F . Effects of astragali radix extract on carcinogenesis, cytokine production, and cytotoxicity in mice treated with a carcinogen, N-butyl-N’butanolnitrosoamine. Cancer Invest. 1999;17:30-35.

21.

Kidd PM . The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev. 2000;5:4-27.

22.

Cha RJ , Zeng DW , Chang QS . Non-surgical treatment of small cell lung cancer with chemo-radio-immunotherapy and traditional Chinese medicine[in Chinese]. Chung Hua Nei Ko Tsa Chih (Chin J Intern Med). 1994;33:462-466.

23.

Kupin VI , Polevaia YEB , Sorokin AM . Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract [in Russian]. Vopr Onkol. 1986;32:21-26.

24.

Kastelan Z , Lukac J , Derezic D , et al. Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma. Anticancer Res. 2003;23:5185-5189.

25.

Carballido J , Alvarez-Mon M , Solovera J , et al. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder. J Urol. 1990;143:29-33.

26.

Wang Z , Zhang Z , Liu Y , et al. Effect of retinoic acid and its complexes with transition metals on human bladder cancer cell line EJ in vitro. Urol Res. 2000;28:191-195.

27.

Hong WK , Itri LM . Retinoids and human cancer. In: Sporn MB , Roberts AB , Goodman DS , eds. The Retinoids: Biology, Chemistry, and Medicine. New York, NY: Raven; 1994: 597-630.

28.

Chen TX , Wanibuchi H , Wei M , et al. Concentration-dependent promoting effects of sodium-L-ascorbate with the same total dose in a rat two-stage urinary bladder carcinogenesis. Cancer Lett. 1999;146:67-71.

29.

Konety BR , Lavelle JP , Pirtskalaishvili G , et al. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J Urol. 2001;165:253-258.

30.

Hermann GG , Andersen CB . Transitional cell carcinoma express vitamin D receptors. Scand J Urol Nephrol. 1997;31:161-166.

31.

Fujioka T , Hasegawa M , Ishikura K , et al. Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma. J Urol. 1998;160:247-251.

32.

Simboli-Campbell M , Narvaez CJ , Tenniswood M , Welsh J . 1,25-dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 1996;58:367-376.

33.

Harris NM , Crook TJ , Dyer JP , et al. Intravesical meglumine gamma-linolenic acid in superficial bladder cancer: an efficacy study. Eur Urol. 2002;42:39-42.

34.

Boik J . Natural Compounds in Cancer Therapy. Princeton, Minn: Oregon Medical Press; 2001.

35.

Clark LC , Combs GF , Turnbull BW , et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA. 1996;276:1957-1963.

36.

Spivak MY . On the use of phytoeides of garlic and onion for the treatment of tumorous patients [in Russian]. Vopr Onkol. 1962;8:93-96.

37.

Jones E . Cancer: Its Causes, Symptoms, and Treatment. Wenatchee, Wash: Healing Mountain; 1911, reprinted 2001.

38.

Farnsworth NR . The phytochemistry and biological activity of Catharnathus lanceus(Apocyanaceae). In: Swain T , ed. Plants in the Development of Modern Medicine. Cambridge, Mass: Harvard University Press; 1972:279-302.

39.

Noble RL , Beer CT , Cutts JH . Role of chance observations in chemotherapy: Vinca rosea. Ann NY Acad Sci. 1958;76:882-894.

40.

Ojima I , Bounaud PY , Takeuchi C , Pera P , Bernacki RJ . New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells. Bioorg Med Chem Lett. 1998;8:189-194.

41.

Chattopadhyay SK , Kumar TR , Maulik PR , et al. Absolute configuration and anticancer activity of taxiresinol and related lignans of Taxus wallichiana. Bioorg Med Chem. 2003;11:4945-4948.

42.

Chen WM , Zhang PL , Wu B , Zheng QT . Studies on the chemical constituents of Taxus yunnanensis[in Chinese]. Yao Xue Xue Bao. 1991;26:747-754.

43.

Zhou DC , Zittoun R , Marie JP . Homoharringtonine: an effective new natural product in cancer chemotherapy. Bull Cancer. 1995;82:987-995.

44.

Chang HM , But PPH , eds. Pharmacology and Applications of Chinese Materia Medica. Vol 1. Hackensack, NJ: World Scientific; 1986.

45.

Kuo YH , Lin CH , Hwang SY , et al. A novel cytotoxic C-methylated biflavone from the stem of Cephalotaxus wilsoniana. Chem Pharm Bull (Tokyo).2000;48:440-441.

46.

Bocar M , Jossang A , Bodo B . New alkaloids from Cephalotaxus fortunei. J Nat Prod. 2003;66:152-154.

47.

Yarnell E . The botanical roots of pharmaceutical discovery. Altern Complement Ther. 2000:6(3):125-128.

48.

Redman BG , Esper P , Pan Q , et al. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin Cancer Res. 2003;9:1656-1672.

49.

Brewer GJ , Merajver SD . Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper—a review. Integr Cancer Ther. 2002;1:327-337.

50.

Meng XL , Riordan NH , Casciari JJ , et al. Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. P R Health Sci J. 2002;21:323-328.

51.

Pienta KJ , Naik H , Akhtah A , et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst. 1995;87:348-353.

52.

Platt D , Raz A . Modulation of the lung cell colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst. 1992;18:438-442.

53.

Theodorescu D , Laderoute KR , Calaoagan JM , Guilding KM . Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression. Int J Cancer. 1998;78:775-782.

54.

Kaufman PB , Duke JA , Brielmann H , Boik J , Hoyt JE . A comparative survey of leguminous plants as sources of the isoflavones genistein and daidzein: implications for human nutrition and health. J Altern Complement Med. 1997;3:7-12.

55.

Silverman DT , Hartge P , Morrison AS , Devesa SS . Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 1992;6:1-30.

56.

Wan XS , Lu LJ , Anderson KE , Ware JH , Kennedy AR . Urinary excretion of Bowman-Birk inhibitor in humans after soy consumption as determined by a monoclonal antibody-based immunoassay. Cancer Epidemiol Biomarkers Prev. 2000;9:741-747.

57.

Armstrong WB , Kennedy AR , Wan XS , et al. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin Cancer Res. 2000;6:4684-4691.

58.

Rural Development Administration . Bowman-Birk protease inhibitor content in soybeans and soybean products. Korea Soybean Digest. 2003;17(1): 61-68. Available at: http://www.fftc.agnet.org/library/article/rh2003007b.html. Accessed December 8, 2004.